Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11168709 | PMC |
| http://dx.doi.org/10.14744/AnatolJCardiol.2024.6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A preliminary experience on the efficacy, safety and short-term results in the treatment of acute bilateral iliofemoral deep vein thrombosis with the Angiojet rheolytic thrombectomy.
J Vasc Surg Venous Lymphat Disord
January 2025
Department of Cardiovascular Surgery, Hitit University Erol Olçok Education and Research Hospital, Çorum, TURKEY.
Background: This study aimed to examine the early clinical outcomes of AngioJet rheolytic thrombectomy (RT) in patients with acute bilateral iliofemoral deep vein thrombosis (IFDVT), with a specific focus on the incidence of post-thrombotic syndrome (PTS).
Methods: From March 2021 to August 2023, sixteen consecutive patients with acute bilateral IFDVT treated with AngioJet RT at our center were evaluated. Primary outcomes include patency of the target veins, development of PTS, recurrent DVT, and procedure related death.
Endovascular therapy for iatrogenic occlusion of the popliteal artery after complex total knee arthroplasty: A case report.
J Vasc Surg Cases Innov Tech
April 2025
Department of Vascular Surgery, St Franziskus Hospital, Münster, Germany.
Iatrogenic arterial injury is an infrequent but limb-threatening complication of total knee arthroplasty (TKA). Open surgical reconstruction may not always be feasible or optimal, particularly in patients who have recently just undergone complex TKA procedures. In this report, we describe the treatment of a patient who developed popliteal artery occlusion following a complex TKA procedure performed the previous day.
View Article and Find Full Text PDFThe rheolytic thrombectomy AngioJet™ is a safe and technically feasible method for treating acute and sub-acute occluding lesions in the visceral arteries.
Int Angiol
November 2024
Department of Vascular and Endovascular Surgery, St. Franziskus Hospital, Muenster, Germany.
Background: The aim of this study is to evaluate the safety and feasibility of the AngioJet™ device in the endovascular treatment of visceral ischemia with stenotic or occlusive lesions.
Methods: Retrospective analysis of patients treated for visceral artery occlusion with thrombectomy using the AngioJet™ (Boston Scientific, MA, USA). Inclusion criteria: patients with stenotic or occluding lesion in visceral arteries including renal and mesenteric arteries, who received endovascular treatment with AngioJet™.
Factors related to acute kidney injury after AngioJet rheolytic thrombectomy.
Acta Radiol
November 2024
Department of Radiology, College of Medicine, Jeonbuk National University, Jeonju, Republic of Korea.
Background: AngioJet rheolytic thrombectomy is associated with a higher risk of acute kidney injury due to its potential for inducing mechanical harm and intravascular hemolysis. However, previous studies have focused on a single disease entity.
Purpose: To identify predictors associated with acute kidney injury after AngioJet rheolytic thrombectomy across a range of disease entities.
Angiojet Rheolytic Thrombectomy, AIZANOI study and COVID-19.
Anatol J Cardiol
June 2024
Department of Cardiology, Ankara University Faculty of Medicine, İbn-i Sina Hospital, Ankara, Türkiye.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!